A director at Tal Education Group sold 53,655 shares at 10.870USD and the significance rating of the trade was 88/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
TAL reported a solid earnings beat for 1QFY26. Revenue grew 39% yoy to US$575m for 1QFY26, in line with our and consensus estimates. Gross profit rose 47% yoy to US$315m, with gross margin expanding 3ppt yoy to 55%. Non-GAAP net profit beat expectations and came in at US$42m vs the street’s estimate of US$31m. Non-GAAP net margin remained flattish yoy at 7% despite stepped-up marketing efforts for AI learning devices. Maintain BUY with an unchanged target price of US$14.00.
KEY HIGHLIGHTS Economics PMI July's manufacturing PMI slipped to 49.3 (-0.4pt mom), while non-manufacturing PMI dropped to 50.1 (-0.4pt mom), as construction activity eased to 50.6 (-2.2pt mom). Slowing demand and rising input costs are slowing the recovery and affecting both large (-0.9pt mom) and small enterprises (-0.9pt mom). Nevertheless, business expectations have improved and should see a further lift from targeted anti-involution measures. Sector Automobile China’s PV insurance regis...
GREATER CHINA Economics PMI Rebound falters, weighed down by weaker construction and input cost pressures. Sector Automobile Weekly: PV sales pressured by anti-involution initiatives. Maintain MARKET WEIGHT on the sector. Top BUYs: CATL, Geely and Tuopu. Results Budweiser APAC (1876 HK/BUY/HK$8.26/Target: HK$12.00) ...
What’s new: New Oriental’s reported 4QFY25 results that were above consensus and our expectations. Guidance implies 1Q rev growth could further decelerate partly due to tougher comps in both core academic segment and East Buy. As comps normalize, rev growth could start to accelerate in 2Q and throughout FY26. We maintain our PT at USD50. Analysts: Jin Yoon
EDU’s 4QFY25 results beat expectations. Revenue grew 9% yoy to US$1,243m, 5% better than our and consensus forecasts. Non-GAAP net profit came in at US$7m, beating our and consensus estimates, while net margin expanded 2ppt yoy to 8% for 4QFY25. EDU expects 1QFY26 revenue to rise 2-5% yoy to US$1,464.1m-1,507.2m, 5- 8ppt below expectations. Maintain BUY with a lower target price of US$55.00 (HK$43.00).
KEY HIGHLIGHTS Sector Healthcare All the healthcare stocks under our coverage exhibited a positive performance from 16-30 July. Due to expectations of strong results for 1H25, CRDMO companies were the top performers, with share prices surging by 22-34%. Supported by major BD/M&A deals, MicroPort, Sino Biopharm and Hengui Medicines also saw their stock prices rise significantly by 65.3%, 16.8% and 13.0%, respectively. Results Contemporary Amperex Technology (300750 CH/BUY/Rmb277.09 /Target: R...
GREATER CHINA Sector Healthcare Bi-Weekly: Expecting strong 1H25 results. Maintain OVERWEIGHT. Results Contemporary Amperex Technology (300750 CH/BUY/Rmb277.09 /Target: Rmb390.00) 2Q25: Earnings in line, with margins hitting record-high levels. Maintain A-share at BUY. Downgrade H-share to HOLD. New Oriental Education & Technology Group (EDU US/BUY/US$44.37/Target: US$55.00) ...
We have an optimistic outlook on the education sector, propelled by the government’s AI+ initiative, industry consolidation and demand for non-academic segments. The education sector remains as a domestically driven industry but we expect easing policies surrounding visa applications to foster demand for overseas education. Meanwhile, we expect AI-powered educational tools to reshape supply-side dynamics in the industry. Maintain MARKET WEIGHT on the sector.
A director at Elders Limited bought 8,000 shares at 6.260AUD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
A director at Zhejiang NHU Co Ltd bought 200,000 shares at 21.400CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
TAL reported disappointing earnings for 4QFY25. Revenue grew 42% yoy to US$610m for 4QFY25, 4% below our and consensus estimates. Gross profit rose 40% yoy to US$318m, with gross margin narrowing 1ppt yoy to 52%. Non-GAAP net profit missed expectations and came in at US$7m vs the street’s estimate of US$50m. Non-GAAP net margin shrank 10ppt yoy to 1% due to stepped-up marketing efforts for AI learning devices amid low seasonality. Maintain BUY with a lower target price of US$14.00.
KEY HIGHLIGHTS Results Aier Eye Hospital Group (300015 CH/BUY/Rmb12.72/Target: Rmb17.80) Aier delivered a relatively modest growth in 2024 but revenue and adjusted net earnings saw robust growth of 15.97% and 25.8% yoy respectively for 1Q25. Management is confident about the growth outlook for Aier given rigid service demand despite the relatively weak economic conditions. Aier has further expanded its hospital network and will continue to improve operating efficiency by actively deploying AI ...
GREATER CHINA Results Aier Eye Hospital Group (300015 CH/BUY/Rmb12.72/Target: Rmb17.80) 2024: Satisfactory results; expects strong recovery in 2025. Upgrade to BUY. Ningbo Tuopu Group Co (601689 CH/BUY/Rmb50.96/Target: Rmb83.00) 4Q24: Earnings up 38.5% yoy, in line. Maintain BUY with target price unchanged at Rmb83.00. TAL Educational Group (TAL US/BUY/US$9.36/Target: US$14.00) 4QFY25: Earnings miss amid ramped-up investments in AI-powered learning. INDONESIA Sector Telecommun...
EDU’s 3QFY25 results missed our expectations. Revenue dropped 2% yoy to US$1,183m, 4% lower than consensus estimate. Non-GAAP net profit came in at US$113m, missing our and consensus estimates, while net margin shrank 1ppt yoy to 10% for 3QFY25. EDU expects 4QFY25 revenue (excluding East Buy) to increase 10-13% yoy to US$1,009.1m-1,036.6m, 5-8ppt below expectations. Maintain BUY with a slightly lower target price of US$60.00 (HK$47.00).
KEY HIGHLIGHTS Results Guangzhou Tinci Materials Technology (002709 CH/BUY/Rmb17.19/Target: Rmb39.60) Tinci’s 1Q25 net profit came in above estimates at Rmb150m (+30.8% yoy/+2.7% qoq), due to higher-than-expected sales volume and ASP. Going forward, Tinci will sustain earnings growth through cost control measures, product upgrading and global capacity expansion. We raise our 2025-26 net profit forecasts by 119%/150% to Rmb887m/ Rmb967m respectively, and introduce our 2027 net profit forecast o...
GREATER CHINA Results Guangzhou Tinci Materials Technology (002709 CH/BUY/Rmb17.19/Target: Rmb39.60) 1Q25: Earnings beat on revenue; raise target price from Rmb18.00 to Rmb39.60. Upgrade to BUY. New Oriental Education & Technology Group (EDU US/BUY/US$43.38/Target: US$60.00) 3QFY25: Earnings miss; subdued top-line but solid margin outlook in 4QFY25. Ping An Healthcare and Technology Company (1833 HK/BUY/HK$7.15/Target:HK$11.00) 1Q25: Results beat; maintains double-digit revenue growth target for...
What’s new: New Oriental’s reported 3QFY25 top-line results that were below consensus and our expectations. Guidance was also below than expected partly due to a continued slowdown in the overseas-related business segments. We maintain our PT at USD50. Analysts: Jin Yoon
Chinese internet companies’ share prices have dropped 10-30% mtd following the implementation of incremental tariffs from the US. Chinese internet companies have limited business exposure to the US except for PDD’s Temu. However, the 34% tariffs announced by China on all US imports could have potential implications for China mega-caps’ AI capex in relation to US chip imports. We prefer domestic-focused plays which stand to benefit from domestic policy stimuli, with Southbound inflow to be a key ...
GREATER CHINA Sector Internet Navigating headwinds and uncovering opportunities upon tariff pressures. INDONESIA Update Erajaya Swasembada (ERAA IJ/BUY/Rp348/Target: Rp480) Iphone 16 series to be available in 2Q25. Maintain BUY. MALAYSIA Update Matrix Concepts Holdings (MCH MK/BUY/RM1.27/Target: RM1.66) We view the RPT deal as fair and strategic as the acquisition allows Matrix to see faster ro...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.